Oxazone 10 - Alphazone Pharmaceuticals

Oxandrolone stands out among anabolic steroids for its early emphasis on safety and tolerability. Introduced as Anavar in 1962 by G.D. Searle & Co., the drug was prescribed for both adult and pediatric patients suffering from muscle loss or hormonal growth delays. Its low androgenic index minimized masculinizing side effects. Though successful clinically, it was discontinued in 1989 due to regulatory pressures. A decade later, it returned as Oxandrin, marketed by BTG for rare wasting diseases and growth disorders with FDA approval under the orphan drug designation program.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Oxazone 10 by Alphazone Pharmaceuticals, consult with your doctor or healthcare professional.